⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IGC News
IGC Pharma, Inc.
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics
accessnewswire.com
VTIX
NTHI
MDCX
YYGH
VVOS
DVLT
ACXP
IGC
CAST
IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout
accessnewswire.com
IGC
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
accessnewswire.com
IGC
VVOS
ACXP
EQX
DVLT
CISO
VTIX
NRXP
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts
accessnewswire.com
IGC
IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease
accessnewswire.com
IGC
Form 8-K
sec.gov
IGC
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness
accessnewswire.com
IGC
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
accessnewswire.com
ACXP
DVLT
IGC
NRXP
SNYR
TRN
VTIX
VVOS
YYGH
MDCX
ATON
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning
accessnewswire.com
IGC
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025
accessnewswire.com
IGC